Prospective Observational Cohort Study to Describe the Use of Vectibix in Combination With Chemotherapy in Routine Clinical Practice for Patients With Wild-type RAS Metastatic Colorectal Cancer
Phase of Trial: Phase IV
Latest Information Update: 13 Dec 2016
At a glance
- Drugs Panitumumab (Primary) ; Antineoplastics
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Amgen
- 07 Dec 2016 Status changed from active, no longer recruiting to completed.
- 26 Feb 2016 Planned End Date changed from 1 Jan 2017 to 1 Nov 2016 as per ClinicalTrials.gov record.
- 04 Dec 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov